4 hours Jasper Therapeutics (NASDAQ:JSPR) Earns “Market Outperform” Rating from JMP Securities MarketBeat
JMP Securities reaffirmed a “market outperform” rating and set a $70.00 price objective on shares of Jasper Therapeutics in a research report on Friday.